Academic literature on the topic '201-300'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '201-300.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "201-300"

1

Rusinovich, O., A. Mora, E. Muñez, L. Delgado Tellez de Cepeda, N. De la Torre, M. Pavía, J. Sanz, M. Espinosa, J. L. Andréu Sánchez, and J. Campos Esteban. "POS1218 SAFETY AND EFFICACY OF ANAKINRA IN SEVERE SARS-COV2 INFECTION (COVID19) AT A TERTIARY HOSPITAL." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 892.2–893. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2590.

Full text
Abstract:
Background:SARS-CoV-2 virus is a novel coronavirus that causes COVID-19 disease, which in its most severe form produces life-threatening atypical pneumonia and ARDS. Coronaviruses induce dysregulation of the immune system resulting in a cytokine storm syndrome with activation of the macrophage mediated mainly by IL-1 and IL-6. Although there is no specific treatment to date, researchers have explored novel approaches through targeting both IL-6 and IL-1. Anakinra is a recombinant human IL-1 receptor antagonist that prevents IL-1β and IL-1α binding and therefore blocks signal transduction. Its high bioavailability, rapid action, relatively short half-life and good safety profile make it a promising drug.Objectives:Analyse the experience of administering Anakinra for severe forms of COVID19 in patients hospitalised at a tertiary hospital.Methods:Retrospective single-center study in which all patients admitted for COVID-19 and treated with Anakinra from April 1st to the end of the 1st wave (July 2020) were included. Medical records were reviewed to collect demographic, clinical and lab test data, using Brescia-COVID respiratory severity scale, SaFi, CRP, Ferritin, LDH and lymphocytes. Variables were assessed at baseline, 72h and 7 days after treatment initiation. Descriptive statistical analysis was performed, including a sub-analysis of patients who received anakinra as the only biological treatment.Results:54 patients were included, of which 37 male (68.5%) with a median age of 69.5 years (36-94). Comorbidities were lung disease 14 pts (25.9%), cardiovascular disease 39 pts (72.2%), Diabetes Mellitus 11 pts (20.4%), kidney disease and rheumatic disease each in 6 pts (11.1%), and immunosuppression 13 pts (24.1%). Each patient received a mean of 4.85 doses of anakinra (± 3.96). Other therapies included low-dose steroids (70.3%); high-dose steroids: 1mg/kg (87%), bolus (24%), Tocilizumab (57.4%), Infliximab (24.1%), Lopinavir/Ritonavir (48%), Hydroxychloroquine (94.4%), and Azithromycin (79.6%). Mortality was 22% overall, 75% due to COVID19, 8.3% due to infectious complications and 16.7% due to non-infectious complications. In the group receiving Anakinra as only biological drug, mortality accounted for 17.9% of patients, 75% due to COVID19 and 25% to non-infectious complications. No adverse effects related to anakinra were observed.General group (n=54)Group receiving anakinra as only biological drug (n=23)PBaselineAfter 72hAfter 7dBaselineAfter 72hAfter 7dBrescia-COVID1.65 (0.95)1.63 (1.13)1.73 (1.19)1.09 (0.8)0.91 (0.88)1.09 (0.8)Mean(SD)Values:Values:Values:Values:Values:Values:NS0: 11.1%0: 16.7%0: 7.9 %0: 26.1%0: 39.1%0: 8.7 %1: 31.5%1: 27.8%1: 52.6%1: 47.8%1: 34.8%1: 82.6%2: 42.6%2: 38.9%2: 18.4%2: 21.7%2: 21.7%2: 8.7%3: 53.7%3: 7.4%3: 7.9%3:4.34%3: 4.34%3: 0%4: 3.7%4: 9.3%4: 13.2%4: 0%4: 0%4: 0%SaFi222.60 (115.2)240.51 (117.6)250.95 (102.6)306.35 (124.7)316.04 (129.8)300.36 (135.4)NSMean (SD)Values:Values:Values:Values:Values:Values:>300:>300:>300:>300:>300:>300:25.9%24.5 %34.2 %56,52%52.2 %45.46 %201-299201-299:201-299:201-299:201-299:201-299:: 14.8%26.4%34.2%17.39%21.7%27.27%<201:<201:<201:<201:<201:<201:59.3%49%31.6%26.1%26.1%27.27%Lymphocytes, 10^3/microLMean (SD)1.07 (1.5)5.16 (3.05)1.15 (2.49)0.88 (0.56)1.25 (0.79)1.15. (2.4)NSFerritine,ng/mlMean (SD)1098.4 (944.8)1080.23 (873.9)1069.19 (989.42)1112.76 (621.80)903.25 (385.49)704.14 (261.86)NSC-reactive protein, mg/LMean (SD)38.78 (37.58)21.46 (20.17)7 (6)50 (6.38)34.67 (23.3)19.96 (28.92)NSLDH, U/LMean (SD)387.64 (163.1)394.98 (209.32)374.26 (157.63)326.38 (111.66)308 (116.59)355 (151.96)NSRespiratory improvement*N/A20.37%51.85%N/A30.43%69.5%.007Lab test improvement**N/A51.85%77.78%N/A60.87%78.2%NS* SaFi normalised or increased 100 mmHg or more** Improvement of 2 or more analytic variablesConclusion:Anakinra in severe SARS-CoV-2 infection offers respiratory improvement and partial lab tests improvement. No adverse effects were observed.Acknowledgements:We wish to acknowledge Puerta de Hierro Majadahonda COVID19 task force and all the patients and staff affected by the pandemic.Disclosure of Interests:None declared
APA, Harvard, Vancouver, ISO, and other styles
2

Lamberts, S. W. J., G. F. F. M. Pieters, H. J. Metselaar, G. L. Ong, H. S. Tan, and J. C. Reubi. "Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours." Acta Endocrinologica 119, no. 4 (December 1988): 561–66. http://dx.doi.org/10.1530/acta.0.1190561.

Full text
Abstract:
Abstract. Two patients with metastatic endocrine pancreatic tumours initially responded well to therapy with the long-acting somatostatin analogue SMS 201-995. In the first patient with an insulinoma both the number of hypoglycemic attacks and the increased insulin levels decreased initially, but returned to pretreatment intensity and concentrations within 9 days after the start of therapy with 200–300 μg SMS 201-995 daily. After a short interruption, no effect was observed of re-institution of therapy at a dose of 400 μg SMS 201-995 daily. In the other patient with a metastatic vipoma both diarrhea, hypokalemia and plasma VIP levels reacted initially well to SMS 201-995 treatment with 300 μg per day, but resistance to therapy developed after 2 weeks. An increase in the dose of the analogue to maximally 600 μg/day was followed by a transient improvement, but finally both the volume of diarrhea and the levels of vasoactive intestinal polypeptide were higher than those before the start of therapy. Conclusions: Development of resistance to SMS 201-995 both with regard to the clinical effect and to the inhibitory effect on tumour hormone secretion can be expected in some patients with metastatic endocrine pancreatic tumours. On the basis of our clinical observations down-regulation of somatostatin receptors is suggested to be one of the mechanisms of this development.
APA, Harvard, Vancouver, ISO, and other styles
3

Lamberts, Steven W. J., Piet Uitterlinden, and Jan M. G. Klijn. "The effect of the long-acting somatostatin analogue SMS 201–995 on ACTH secretion in Nelson's syndrome and Cushing's disease." Acta Endocrinologica 120, no. 6 (June 1989): 760–66. http://dx.doi.org/10.1530/acta.0.1200760.

Full text
Abstract:
Abstract. Chronic therapy of a patient with Nelson's syndrome for 2 years with 300 μg SMS 201–995 per day resulted in a significant decrease in circulating ACTH levels, normalization of the visual field defect and of loss of visual acuity of one eye, and stabilization of tumour growth, without radiological evidence of shrinkage of the pituitary tumour. In two other patients with Nelson's syndrome, SMS 201–995 acutely inhibited circulating ACTH levels. This effect could be shown best if cortisol replacement was temporarily withheld. SMS 201–995 did not affect plasma ACTH and cortisol levels in three patients with untreated Cushing's disease.
APA, Harvard, Vancouver, ISO, and other styles
4

Baloch, Sana Fatima, Ikram Din Ujjan, Sadia Shahmeer, Nazia Hafeez, Kiran Amir, and Abdul Rehman. "Reproductive Hormone in Transfusion dependent βeta thalassemia major patients." Professional Medical Journal 26, no. 12 (December 10, 2019): 2179–83. http://dx.doi.org/10.29309/tpmj/2019.26.12.3703.

Full text
Abstract:
Objective: To evaluate endocrine profile in transfusion dependent beta-thalassemia major patients. Study Design: Descriptive cross sectional study. Setting: Department of Pathology Liaquat University of Medical and Health Sciences, Jamshoro /Hyderabad and Thalassemia Centre Hyderabad. Period: 6 months from January 2018 to June 2018. Material & Methods: Cases already diagnosed with β- thalassemia major with recurrent blood transfusions (>20 transfusions or transfusion period over 2 years) both genders were included. All the patients went through routine laboratory checkups including Testosterone hormone, Luteinizing Hormone, and Follicle Stimulating Hormone. Data was recorded in preplanned proforma. Results: Overall 114 subjects were studied and their mean age was found to be 12.38+5.71 years. Females remained in majority as 56.1%. Mean of follicle stimulate hormone (FSH) and luteinizing hormone (LH) level were 4.60+4.88 and 5.39+8.39 respectively. Most of the patients, 35.1% had >300 of transfusion rate. Ferritin levels were significantly correlated with patients with history of transfusion rate >300; p-value 0.003. Testosterone level’s mean was considerably high among patients presented with transfusion rate of 201 to 300 and >300 transfusions; p-value 0.006. Likewise, mean of FSH and LH level was as well significantly high among the female subjects with history of transfusion rate of 201 to 300 and >300 transfusions; P-Values 0.019 and 0.026 respectively. Conclusion: Frequent hypogonadism was noted among thalassemia patients. Very low level average of FSH, LH and testosterone was seen.
APA, Harvard, Vancouver, ISO, and other styles
5

Freid, Rachel D., Ying (Shelly) Qi, Janice A. Espinola, Rebecca E. Cash, Zahra Aryan, Ashley F. Sullivan, and Carlos A. Camargo. "Proximity to Major Roads and Risks of Childhood Recurrent Wheeze and Asthma in a Severe Bronchiolitis Cohort." International Journal of Environmental Research and Public Health 18, no. 8 (April 15, 2021): 4197. http://dx.doi.org/10.3390/ijerph18084197.

Full text
Abstract:
Air pollution exposures have been suggested as risk factors for childhood respiratory diseases. We investigated proximity to major roads, an indicator of air pollution exposure, and its associations with childhood recurrent wheeze and asthma. We used data from a multicenter prospective cohort study of 921 infants hospitalized for bronchiolitis and recruited from 14 U.S. states. Primary exposure was residential proximity to the nearest major road at birth through age 3 years. Residential distance from nearest major road was divided into four categories: <100, 100–200, 201–300, and >300 m. Outcomes were parent-reported recurrent wheeze by age 3 years and asthma by age 5 years. Associations between residential proximity to major roads and respiratory outcomes were investigated using multivariable Cox proportional hazards modeling and logistic regression, adjusted for confounders. Out of 920 participants with home address data, pooled estimates identified 241 (26%) participants resided within 300 m of a major road, 296 (32%) developed recurrent wheeze by age 3, and 235 out of 858 participants (27%) developed asthma by 5 years. Participants who resided close to a major road had the highest risk of recurrent wheeze (adjusted hazards ratio for <100 m, 1.59, 95%CI: 1.08–2.33) and asthma (adjusted odds ratio for 201–300 m, 1.62, 95%CI: 1.16–2.25), compared to those residing >300 m from a major road. Proximity to major roads is associated with increased risks of recurrent wheeze and asthma in young children.
APA, Harvard, Vancouver, ISO, and other styles
6

Malena, M., E. Voslářová, A. Kozák, P. Bělobrádek, I. Bedáňová, L. Steinhauser, and V. Večerek. "Comparison of Mortality Rates in Different Categories of Pigs and Cattle during Transport for Slaughter." Acta Veterinaria Brno 76, no. 8 (2007): S109—S116. http://dx.doi.org/10.2754/avb200776s8s109.

Full text
Abstract:
The death of animals during transport for slaughter is a major factor indicating the level of welfare in transported animals. However, research data that report the level of animal welfare as reflected in transport-related mortality rates of individual animal species and categories are missing. The present study focused on losses of pigs and cattle in the period from 1997 to 2006. Transport-related mortality rates were recorded by species and categories of animals and also for the following travel distances: up to 50 km, 51-100 km, 101-200 km, 201-300 km, and over 300 km. Rates differed according to species and category. The highest mortality rates were found in young sows, sows, and boars (0.2562%) followed by fattened pigs (0.1075%), excluded dairy cows (0.0396%), calves (0.0269%), and fattened cattle (0.0069%). Significant differences were found among mortality rates (p < 0.05). The lowest mortality rates occurred with shorter travel distances (< 50 km and 51-100 km) when compared to long travel distances (101-200 km, 201-300 km and > 300 km), with a significant difference (p < 0.05) between short and long travel distances being found in fattened pigs, fattened cattle and dairy cows. Mortality rates in animals during transport for slaughter show young sows, sows, and boars to be the most susceptible to transport-related stress, followed by fattened pigs, dairy cows, and calves, whereas the highest resistance was observed in fattened cattle.
APA, Harvard, Vancouver, ISO, and other styles
7

Fizazi, Karim, Christophe Massard, Nicholas David James, Stephane Culine, Robert Hugh Jones, Riikka Oksala, Anu Moilanen, Eija Aho, Laura Ravanti, and Pekka Kallio. "ODM-201, a new generation androgen receptor inhibitor for castration-resistant prostate cancer: Preclinical and phase I data." Journal of Clinical Oncology 31, no. 6_suppl (February 20, 2013): 65. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.65.

Full text
Abstract:
65^ Background: Castration resistant prostate cancer (CRPC) is characterized by persistent, high level androgen receptor (AR) expression and resistance to conventional AR inhibitors. ODM-201 is a novel AR inhibitor with unique pharmacologic properties that has shown promising results in preclinical and clinical studies. Methods: AR binding affinity of ODM-201 to wild type AR was determined in cytosolic lysates obtained from ventral prostates of castrated rats using a competition binding assay. Additionally, effects of ODM-201 on the growth of castration resistant VCaP tumors was evaluated. Tumors were established by subcutaneous injection of VCaP prostate cancer cells into male nude mice. After initial tumor growth, mice were castrated. ODM-201 (50 mg/kg QD or BID orally) was initiated upon tumor regrowth. Since the risk of seizures has been reported for some second generation AR inhibitors, ODM-201 concentrations in mouse brain homogenates were studied after repeated oral administration to assess the risk. The clinical effects of ODM-201 (100, 200, 300, 500, 700, 900 mg BID) was examined in a Phase I/II dose-escalation trial in patients (N=24) with progressive metastatic CRPC. Results: ODM-201 binds to wild type AR with superior affinity compared to enzalutamide (Ki of 9 and 39 nM, respectively). In the VCaP CRPC model, ODM-201 significantly (p<0.001 compared to castrated control), and more efficiently than enzalutamide, inhibited tumor growth. After oral administration, tissue/plasma ratio of ODM-201 in mouse brain homogenates was negligible in all studied doses. In the Phase I/II clinical study, ODM-201 (100 to 700 mg results available) was well tolerated, and most commonly reported adverse events were asthenia, diarrhea and nausea. A PSA response (defined as ≥ 50% decrease) was obtained in 13/15 patients evaluable at 12 weeks with all patients achieving partial response or stable disease by RECIST/PCWG2 criteria. Conclusions: ODM-201 is a new generation AR inhibitor with superior preclinical efficacy compared to enzalutamide and bicalutamide, it does not enter the brain in preclinical studies, and it shows very promising activity and no significant toxicity in patients with CRPC. Clinical trial information: NCT01317641.
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Pingwei, Juanita R. Weissensteiner, Johan Pion, and Veerle De Bosscher. "Predicting elite success: Evidence comparing the career pathways of top 10 to 300 professional tennis players." International Journal of Sports Science & Coaching 15, no. 5-6 (June 19, 2020): 793–802. http://dx.doi.org/10.1177/1747954120935828.

Full text
Abstract:
The aim of this research was to explore at what age professional tennis players at different ranking levels (top 10, 11-20, 21–50, 51–100, 101–200, 201–300) started playing tennis and had achieved their career ranking milestones, and to explore the viability of using age and ranking to predict a player’s future success. 373 top 300 ranked professional tennis players from 2010 to 2018, including 193 females (M = 32.3, SD = 3.5) and 180 males (M = 34.0, SD = 3.1) were examined. Descriptive methods and univariate analyses were used to compare player developmental trajectories by player peak ranking levels. Discriminant analyses were applied to explore to what extent age and early ranking milestones can be used to predict a player’s future peak rankings. Results revealed that there were no significant differences regarding the age at which players started playing tennis by players’ career peak ranking levels. Results showed that 75% of the top 300 players started playing tennis between the ages of 3 to 7 years, whilst 21% started between 7 to 10 years, and 4% started later between 10 to 13 years. Results further showed that professional rankings between 14 and 18 years were not reliable in predicting a player’s future ranking. Closer analyses revealed that age and early rankings have a relatively high value in “predicting” the ranking of higher-ranked (e.g., top 10) and lower-ranked (e.g., top 201–300) players, but not middle-ranked players (i.e. top 11–200), with nearly 60% of them not correctly classified and the top 51–100 ranked players having the lowest predictability.
APA, Harvard, Vancouver, ISO, and other styles
9

Yuan, Lin, Yuan Gao, Wei Zhang, Cheng Lei Wang, Zhi Kang Ma, and Hang Wei Cai. "Effect of Negative Bias Voltage on Corrosion Resistance of TiN Coating Deposited by MAIP." Advanced Materials Research 399-401 (November 2011): 1898–902. http://dx.doi.org/10.4028/www.scientific.net/amr.399-401.1898.

Full text
Abstract:
In this study, TiN coatings were deposited on 201 stainless steel by multi-arc ion plating (MAIP). The effect of negative bias voltage on the surface microstructure, hardness, phase structure and the corrosion resistance of the coatings were investigated by SEM, hardness instrument, XRD and electrochemical measurement. The number and size of droplets decreased when the negative bias voltage increased from -100 V to -300 V. But when the substrate bias increased to a certain value, there were some pits appeared. The hardness increased at first and decreased later with the increasing of the negative bias voltage. When the negative bias voltage was -200 V, the hardness was the highest. The intrinsic hardness of TiN film was 2195HV. In 3.5% NaCl solution, the corrosion resistance of TiN coatings samples were improved slightly compared with 201 stainless steel. In l mol/L H2SO4 solution, the corrosion resistance of -100V sample was the best, the corrosion resistance of -100V coating sample was increased 486 times compared with untreated 201 stainless steel.
APA, Harvard, Vancouver, ISO, and other styles
10

Al Nooryani, Arif, Wael N. Elabbassi, Bassam AlBaba, Jalal A. Kerfes, Loai M. Abudaqa, Amit Bhatia, Nagwa A. Abdelrahman, Nikola Boskovic, and Branko Beleslin. "Long-term outcome of first 300 implanted Absorb bioresorbable vascular scaffolds in an all-comers Middle East population." Journal of International Medical Research 47, no. 1 (September 21, 2018): 173–87. http://dx.doi.org/10.1177/0300060518798994.

Full text
Abstract:
Objectives To evaluate long-term clinical outcomes of the Absorb bioresorbable vascular scaffold (BVS) system (Abbott Vascular) in an all-comers Middle East population. Methods This prospective registry study included an initial set of patients with coronary lesions treated using Absorb BVS. Patients were followed for target vessel failure (TVF) including cardiac death, target vessel myocardial infarction (MI), and target lesion revascularization. Results A total of 217 patients (age, 55 ± 11 years; male, 169) with 300 treated lesions were included (median follow-up, 36 months [range, 26–41 months]; complete follow-up, 201 patients). Diabetes mellitus and acute coronary syndrome were present in 50% and 57% of patients, respectively. TVF rate was 32/201 (15.9%), including cardiac death in 10 (5%), target vessel MI in 13 (6.5%), and target lesion revascularization in 22 patients (10.9%). Definite or probable device thrombosis occurred in 11/201 patients (5.5%). TVF was associated with heart failure, worse ejection fraction, multi-vessel BVS, multi BVS in lesion, and total BVS length >50 mm. Conclusions Long-term outcome following Absorb BVS implantation in a population with high prevalence of high-risk and complex patients is acceptable, but heart failure, worse ejection fraction, and multi-vessel or long BVS implantation were associated with worse outcomes.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "201-300"

1

Paolo, Vian, ed. Tavole e indici generali dei volumi 201-300 di "Studi e testi". Città del Vaticano: Biblioteca apostolica vaticana, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Library, Hartley. A guide to the archive and manuscript collections of the Hartley Library, University of Southampton: MSS 201-300. Southampton: University of Southampton, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Willems, Mo. We are growing! Los Angeles: Hyperion Books, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tabor, Corey R. Fox the tiger. New York, NY: Balzer & Bray, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

ill, Truesdell Sue, ed. Chicken said, "Cluck!". New York: HarperCollins, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Willems, Mo. Shui zai kan wo men! Taibei Shi: Ge lin wen hua shi ye gu fen you xian gong si, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Willems, Mo. A big guy took my ball! sike. New York: Hyperion Books for Children, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Willems, Mo. Ni de tou shang you zhi niao. Nanning Shi: Jie li chu ban she, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Willems, Mo. There is a bird on your head! London: Walker, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Willems, Mo. There is a bird on your head! New York: Hyperion, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "201-300"

1

Rainsberger, Livia. "Fragen 201 bis 300: LEISTUNGSPORTFOLIO – 100 Fragen zur Gestaltung und Optimierung des Angebotsportfolios." In Edition Sales Excellence, 81–113. Wiesbaden: Springer Fachmedien Wiesbaden, 2024. http://dx.doi.org/10.1007/978-3-658-43783-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Guelachvili, Guy, and Nathalie Picqué. "16O3 Anharmonic- and Coriolis-Type Coupling Parameters of Nine Interacting Vibrational States (012), (111), (201), (130), (003), (102), (201), (300) Including the Dark State (040)." In Molecular Constants Mostly from Infrared Spectroscopy, 55–56. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-57960-2_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Guelachvili, Guy, and Nathalie Picqué. "16O3 Vibrational Energy and Rotational and Centrifugal Distortion Constants for the Tetrad {(003), (102), (201), (300)} and the (130) States." In Molecular Constants Mostly from Infrared Spectroscopy, 49–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-57960-2_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Guelachvili, G., and N. Picqué. "Table 7. H2 17O (H17OH): Molecular constants for the vibrational states (003), (201), (102), (300), (121), (022), (220), (041), (140), and (070) of the first decade." In Non-linear Triatomic Molecules, 84–85. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-32188-7_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Guelachvili, G., and N. Picqué. "Table 22. D2 16O (D16OD): Spectroscopic parameters for the (003), (201), (121), (041), (102), (300), (022), (220), and (140) interacting vibrational states belonging to the first decade." In Non-linear Triatomic Molecules, 123–25. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-41449-7_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Guelachvili, G., and N. Picqué. "Table 23. D2 16O (D16OD): Fermi coupling constants for the (003), (201), (121), (041), (102), (300), (022), (220), and (140) interacting vibrational states belonging to the first decade." In Non-linear Triatomic Molecules, 126. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-41449-7_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Guelachvili, G., and N. Picqué. "Table 24. D2 16O (D16OD): Coriolis coupling constants for the (003), (201), (121), (041), (102), (300), (022), (220), and (140) interacting vibrational states belonging to the first decade." In Non-linear Triatomic Molecules, 127–28. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-41449-7_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Guelachvili, G., and N. Picqué. "Table 8. H2 17O (H17OH): Fermi and Coriolis coupling constants for the vibrational states (003), (201), (102), (300), (121), (022), (220), (041), (140), and (070) of the first decade." In Non-linear Triatomic Molecules, 86–87. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-32188-7_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Guelachvili, Guy, and Nathalie Picqué. "16O3 Number of Levels, Range of Quantum Numbers for Observed Rovibrational Levels of the (012), (111), (201), (130), (003), (102), (201), (300) Vibrational States. Band Centers for the ν2 + 2ν3, ν1 + ν2 + ν3, 2ν1 + ν2, ν1 + 3ν2, 3ν3, ν1 + 2ν3, 2ν1 + ν3, 3ν1, and Dark 4ν2." In Molecular Constants Mostly from Infrared Spectroscopy, 57. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-57960-2_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"201 - 300." In The Innovator’s Dictionary, 454–640. De Gruyter, 2020. http://dx.doi.org/10.1515/9783110677287-011.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "201-300"

1

Юдин, А. И. "Раскопки поселений в Ростовской области и Краснодарском крае." In Археологические открытия 2017 год. Crossref, 2019. http://dx.doi.org/10.25681/iaras.2019.978-5-94375-300-8.197-201.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hanus, Gabriela. "POLISH CONSUMERS’ ATTITUDES TOWARDS ONLINE GROCERY SHOPPING." In NORDSCI Conference Proceedings. Saima Consult Ltd, 2021. http://dx.doi.org/10.32008/nordsci2021/b2/v4/12.

Full text
Abstract:
The primary focus of this study was to explore the attitudes of consumers in Poland towards online grocery shopping, and the impact of the COVID-19 pandemic on the e-grocery market. A direct survey was conducted on a sample of 800 respondents from across Poland in the first quarter of 2020. A questionnaire was used as a research tool. As revealed by data analysis, in 2020 more than a half (60%) of consumers in Poland shopped for groceries in online stores run by brick-and-mortar grocery chains. The respondents usually shopped for groceries several times a month, preferably choosing products with a long shelf life, and home delivery options, each time spending around PLN 201-300. Convenience was found to be the key driver that encouraged consumers to shop for groceries online, and concerns about the quality of products purchased online was the major disincentive. Moreover, the coronavirus pandemic, and the resulting health concerns, were shown to have the least effect on the willingness of respondents to shop for groceries online, or the frequency of online grocery shopping. From a practical point of view, this research can be used to create marketing strategies for enterprises operating in the food retail industry, as well as to expand knowledge about the dynamically developing e-grocery market in Poland.
APA, Harvard, Vancouver, ISO, and other styles
3

Siddiqui, A., R. Bjorklund, M. Bainsmith, and J. Karz. "E-201 Pre-clinical evaluation of a novel liquid embolic for neurovascular applications." In SNIS 20th Annual Meeting Abstracts. BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd., 2023. http://dx.doi.org/10.1136/jnis-2023-snis.300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tao, Wen-Quan, Ya-Ling He, Gui-Hua Tang, and Zhuo Li. "No New Physics in Single-Phase Fluid Flow and Heat Transfer in Mini- and Micro-Channels: Is It a Conclusion?" In ASME 2008 First International Conference on Micro/Nanoscale Heat Transfer. ASMEDC, 2008. http://dx.doi.org/10.1115/mnht2008-52007.

Full text
Abstract:
First the flow friction characteristics of nitrogen and helium in stainless steel microtubes, glass microtubes, square glass microchannels, and rectangular silicon microchannels are tested. The data in glass microtubes with diameters from 50 to 201 microns and in square glass channels with characteristic diameters from 52 to 100 microns show that the friction factors are in good agreement with the conventional predictions. The friction factors in stainless-steel tubes with diameters from 119 to 300 microns are much higher than the conventional ones. The results for two of the four silicon microchannels with characteristic diameters from 26–60 microns are in good agreement while those of the other two channels are larger. This discrepancy is resulted from the large relative surface roughness. Smaller friction factors in glass microtubes with diameters from 10 to 20 microns are obtained due to the rarefaction effect. Second the flow friction experimental data for deionized water flow in glass microtubes with diameters from 50 to 530 microns show that friction factors and transition Reynolds numbers are in good agreement with the conventional predictions. However, the friction factors in stainless steel microtubes with diameters from 50–1570 microns are much higher than the conventional predictions. This discrepancy is attributed to the large surface relative roughness or denser roughness distribution. Numerical simulations considering electroviscous effect are carried out. The simulation results show that the electroviscous effect does not play a significant role in the friction factor for channel dimensions of the order of microns though it does affect the velocity profile and hence it could be neglected in engineering applications for channel dimensions of the order of microns. Third the measured local Nusselt number distribution of deionized water along the axial direction of the stainless steel tubes of 373–1570 microns with uniform heat flux do not accord with the conventional results when Reynolds number is low and the relative thickness of the tube wall is high. Numerical study reveals that the large ratio of wall thickness to tube diameter at low Reynolds number causes significant axial heat conduction in the tube wall, leading to a non-linear streamwise distribution of the fluid temperature. The axial wall heat conduction effect is gradually weakened with the increase of Reynolds number and the decrease of the relative tube wall thickness. In conclusion, the conventional fluid flow and heat transfer theories should still be applied for single-phase flow in smooth microchannels. Nevertheless, micro-channels do raise some issues to be paid special attention to when being applied.
APA, Harvard, Vancouver, ISO, and other styles
5

Tatsuzawa, Masashi, Tomoki Taoka, Takeshi Sakida, and Shinya Tanaka. "Development of 300kW-Class Ceramic Gas Turbine (CGT301) Engine System." In ASME 1995 International Gas Turbine and Aeroengine Congress and Exposition. American Society of Mechanical Engineers, 1995. http://dx.doi.org/10.1115/95-gt-201.

Full text
Abstract:
CGT301 is a recuperated, single-shaft ceramic gas turbine for co-generation use. Ceramic parts are used in the hot section of the engine, such as turbine blades, nozzle vanes, combustor liners, heat exchanger elements and gas path parts. These ceramic parts are designed axi-symmetrically to reduce their sizes and thermal stresses and to avoid their unexpected deformations. The turbine is a two-stage axial flow type. As a primary feature of this turbine, the rotors are composed of ceramic blades inserted into metallic disks. The ceramic parts of the engine system have been tested before installing them in the engine to assure their reliability in the following manner. The ceramic blades have been examined by hot-spin test with the gas temperature of 1100°C and up to 110% of the engine rated speed. The ceramic stationary parts such as nozzle vanes, combustor liners and gas path parts, have been assembled and installed in a test rig with almost the same constraint and thermal conditions as the engine, and thermal fatigue tests of 100 cycles between 1200°C and 300°C have been conducted. After the proof tests of ceramic parts, they have been installed in the engine, step by step. Finally, the engine has been operated with a TIT of 1200°C at the engine rated speed of 56000 rpm. The present paper describes the development process and shows test results of the ceramic gas turbine at a TIT of 1200°C.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography